Table 7.
Cardiac manifestation | CMR utility | Sequences |
---|---|---|
What has CMR to offer in polymyositis/dermatomyositis? | ||
Valvular heart disease | Assessment of hemodynamic significance. Reproducible follow-up. |
Cine—SSFP, cine-FGE PhC, 4D-flow |
Pulmonic hypertension | The severity and hemodynamic significance. Orientation to the potential etiology. |
Cine—SSFP Real-time cine 4D-flow MRA |
Myocardial edema | Identification and quantification Follow up |
T2-W, T2-W-STIR T2-mapping |
Myocarditis | Identification and quantification. Follow up free of radiation. |
T2-W-STIR T1, T2-mapping, ECV LGE-PSIR |
Myocardial inflammation | Identification and quantification. Follow up free of radiation. |
T1-W pre, and post-Gd T1 mapping, ECV LGE-PSIR |
RV dysfunction | The gold standard for RV function | Cine—SSFP Strain |
LV dysfunction | The gold standard for LV function | Cine—SSFP Strain, diffusion tensor |
SSFP, steady-state free precession; FGE, fast gradient echo; T2-W, T2-weighted; STIR, short tau inversion recovery; LGE, late gadolinium enhancement; PSIR, Phase-sensitive inversion recovery; ECV, extracellular volume; MRA, magnetic resonance angiography; Gd, gadolinium.